DistantNews
Support us
🇫🇯 Fiji /Sports

Fiji committee allows players with pending drug cases to return to play

From FBC News · () English

Translated from English and summarized by DistantNews. Read the original for the full story.

At a glance

News Named sources In the courts
  • Fiji FA’s disciplinary committee allowed players with pending drug cases to resume playing.
  • France Catarogo returned for Labasa’s 1-0 win over Nasinu after receiving clearance shortly before the match.
  • Fiji FA chief executive Mohammed Yusuf said decisions in the cases should come within weeks.

France Catarogo returned to the field for Labasa after Fiji Football Association’s disciplinary committee allowed players with pending drug cases to play. Labasa defeated Nasinu 1-0 in the opening pool match of the Extra Battle of the Giants.

Catarogo had been suspended after failing a drug test at the BiC Fiji FACT in Labasa in June. Labasa initially left the number nine shirt vacant on its Battle of the Giants squad list while awaiting the outcome of his appeal.

The committee gave Catarogo permission to play at 1 p.m., two hours before Labasa’s match. He said he felt relieved and grateful to represent his hometown again.

Fiji FA chief executive Mohammed Yusuf said the decision applied to all players with pending drug cases while the disciplinary process continues. Lautoka players Veleni Rasorewa and Epeli Leiroti had also been cleared to play, although their cases remain pending.

Yusuf said the Lautoka legal submission should be finalized within weeks. He said the players had been released to ensure they suffered no procedural harm while the legal matter proceeded.

I am relieved and grateful for the opportunity to represent my hometown once again.

· France CatarogoCatarogo described his reaction after receiving clearance to return for Labasa.
About this summary

Originally published by FBC News in English. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.